UBP551

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555174

CAS#: 89-35-0

Description: UBP551 is a potent and selective modulator of NMDA receptors.


Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-10-31. Prices are subject to change without notice.

UBP551 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 555174
Name: UBP551
CAS#: 89-35-0
Chemical Formula: C11H8O4
Exact Mass: 204.0423
Molecular Weight: 204.181
Elemental Analysis: C, 64.71; H, 3.95; O, 31.34


Synonym: UBP551; UBP-551; UBP 551.

IUPAC/Chemical Name: 3,5-Dihydroxynaphthalene-2-carboxylic acid

InChi Key: YELLAPKUWRTITI-UHFFFAOYSA-N

InChi Code: YELLAPKUWRTITI-UHFFFAOYSA-N

SMILES Code: O=C(C1=C(O)C=C2C(O)=CC=CC2=C1)O


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Monaghan DT, Irvine MW, Costa BM, Fang G, Jane DE. Pharmacological modulation
of NMDA receptor activity and the advent of negative and positive allosteric
modulators. Neurochem Int. 2012 Sep;61(4):581-92. doi:
10.1016/j.neuint.2012.01.004. Epub 2012 Jan 17. Review. PubMed PMID: 22269804;
PubMed Central PMCID: PMC3360989.

2: Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Skifter DA, Jane DE,
Monaghan DT. A novel family of negative and positive allosteric modulators of
NMDA receptors. J Pharmacol Exp Ther. 2010 Dec;335(3):614-21. doi:
10.1124/jpet.110.174144. Epub 2010 Sep 21. PubMed PMID: 20858708; PubMed Central
PMCID: PMC2993558.